Naproxen Oral Suspension
Product Images NDC 70954-151

2 FDA label images from Ani Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Naproxen Oral Suspension (NDC 70954-151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Naproxen showing the molecular formula C14H14O3 and molecular weight 230.26. The structure includes a naphthalene ring system with a methoxy group and a carboxylic acid (R=COOH) functional group.*
FDA Label Image

Label (Naproxen Label)

Label (Naproxen Label)
Label for Naproxen Oral Suspension USP 125 mg/5 mL by Novitium Pharma, a 500 mL oral suspension. The label includes instructions to shake well before use, storage conditions of 20° to 25°C, and tamper-evident warnings. It also states Rx only and notes pharmacist dispensing instructions and medication guide inclusion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.